Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) Sees Large Increase in Short Interest

Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) saw a significant growth in short interest in August. As of August 31st, there was short interest totalling 3,700 shares, a growth of 32.1% from the August 15th total of 2,800 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

Kissei Pharmaceutical Price Performance

Shares of OTCMKTS KSPHF remained flat at $21.48 during trading hours on Monday. Kissei Pharmaceutical has a 52-week low of $19.32 and a 52-week high of $21.48. The company has a 50 day moving average price of $20.70 and a 200-day moving average price of $21.56.

Kissei Pharmaceutical Company Profile

Kissei Pharmaceutical Co, Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Kalogra tablets, for the treatment of ulcerative colitis; Tabuneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Minirin Melt OD tablets; Malizeb tablets; Tavaris tablets for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia.